Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study
2025/01/14 by Jian Rong, Xueqin Wang, Pan Cheng +2 · 25 citations
Psychology · #Child Abuse and Trauma #Mental Health Treatment and Access #Child and Adolescent Psychosocial and Emotional Development
paper · pdf · doi:10.1192/bjp.2024.266
Abstract
BACKGROUND: Depressive disorders pose a significant global public health challenge, yet evidence on their burden remains insufficient. AIMS: To report the global, regional and national burden of depressive disorders and their attributable risk factors from 1990 to 2021. METHODS: Data from the Global Burden of Disease 2021 were analyzed for 204 countries and territories from 1990 to 2021. We explored the age-standardised incidence, prevalence and disability-adjusted life years (DALYs) of depressive disorders by age, gender and sociodemographic index. RESULTS: In 2021, there were 357.44 million incident cases, 332.41 million prevalent cases and 56.33 million DALYs. Age-standardised rates for incidence, prevalence and DALYs were 4333.62, 4006.82 and 681.14 per 100 000 persons, with annual declines of 0.06%, 0.03% and 0.04%. Uganda, Greenland and Lesotho had the highest prevalence, while Spain, Mexico and Uruguay showed the largest increases. Greenland and Brunei Darussalam had the highest and lowest age-standardised DALYs rates, respectively. DALYs peaked in the 55-59 age group for men and 60-64 for women, with higher rates in women. Regionally, a U-shaped association was found between the sociodemographic index and DALYs rates. Population growth was the main driver for the increase in DALYs cases. Childhood maltreatment was the leading risk factor, with intimate partner violence affecting more females and childhood sexual abuse more males. CONCLUSIONS: Despite decreasing trends in incidence, prevalence and DALYs rates, absolute case numbers and age-standardised rates continue to increase for depressive disorders. Tackling childhood abuse and improving depressive disorder management are crucial to reducing future burdens.
Cited by
- Associations Between Mediterranean Diet, Processed Food Consumption, and Symptoms of Anxiety and Depression: Cross-Sectional Study Among Israeli Adults. [europepmc]
- Global, regional and national burden of depressive disorders in adolescents and young adults, 1990-2021: systematic analysis of the global burden of disease study 2021. [europepmc]
- Differential Effects of Repetitive Transcranial Magnetic Stimulation on Mood and Pain Symptoms in People With Chronic Pain and Major Depressive Disorders-A Review. [europepmc]
- Global, regional, and national burden and trends of depressive disorders among women of childbearing age from 1990 to 2021: insights from GBD 2021. [europepmc]
- The effectiveness of a multi-dimensional intervention model combining cognitive behavioral therapy and social support in hospitalized depressed patients. [europepmc]
- Efficacy of Gut Microbiome-Targeted Interventions on Mental Health Symptoms in Women Across Key Hormonal Life Stages: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [europepmc]
- Association between atherogenic index of plasma and depression risk: a meta-analysis. [europepmc]
- Bibliometric analysis of trends, innovations, and the future of CBT-based mobile interventions for depression. [europepmc]
- An Update on the Effect of Physical Exercise on Depressive Disorder: A Systematic Review with Meta-Analysis and Meta-Regression of Randomized Controlled Trials. [europepmc]
- Cross-national comparison of major depressive disorder burden in China, India, and the United States of America: an age-period-cohort analysis of GBD 2021. [europepmc]
- Development of an explainable machine learning model for predicting depression in adults with type 2 diabetes mellitus: A cross-sectional SHAP-based analysis of NHANES 2009-2023. [europepmc]
- Association Between Triglyceride-Glucose-Body Mass Index and Depression in Elderly Diabetic Individuals: A Population-Based Study. [europepmc]
- Dynamic Exploration of Resting-State Brain Attractors Altered in Major Depressive Disorder. [europepmc]
- Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor use and sexual dysfunction: a pharmacovigilance analysis. [europepmc]
- Glucagon-like peptide-1 receptor agonists and risk of depression: a systematic review and meta-analysis. [europepmc]
- Triglyceride-glucose index, genetic predisposition, and incident depression: a prospective cohort study from the UK Biobank. [europepmc]
- Serotonin syndrome risk with concomitant opioid and serotonergic antidepressant use: a multinational pharmacovigilance study. [europepmc]
- Triangulating the link between depression and liver disease: An integrative analysis of genetic, observational, and research trend data. [europepmc]
- Effects of different exercise interventions on depression and anxiety in cancer survivors: a systematic review and Bayesian network meta-analysis of randomized controlled trials. [europepmc]
- Estrogen Replacement Therapy in Ovariectomized Rats: Complementary Roles of ER and GPR30 in Alleviating Depressive-like Behavior. [europepmc]
- Next-Generation Pharmacotherapy for Depressive Disorders: From Novel Compounds to Optimized Use of Available Drugs. [europepmc]
- Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers. [europepmc]
- Building evidence on digital psychotherapies for adults living with depression: a systematic scoping review of populations, interventions and design features of ongoing and planned randomised controlled trials. [europepmc]
- Association of vitamin D deficiency with incident depression in patients with hearing impairment: an observational retrospective cohort study. [europepmc]
- Development of a Traditional Chinese Medicine Lifestyle Medicine Program for Depression: A Multi-Method Study [europepmc]
Related